ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic
- PDF / 161,108 Bytes
- 3 Pages / 595.276 x 790.866 pts Page_size
- 68 Downloads / 174 Views
POSITION STATEMENT
ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic Brenna M. Farmer 1 & Jon B. Cole 2 & Travis D. Olives 3 & Natalija M. Farrell 4,5 & Rama Rao 6 & Lewis S. Nelson 7 & Maryann Mazer-Amirshahi 8 & Andrew I. Stolbach 9 Received: 4 June 2020 / Revised: 10 June 2020 / Accepted: 11 June 2020 # American College of Medical Toxicology 2020
Keywords Toxicology . COVID-19 . Coronavirus . Pharmacy . Medication safety
The position of the American College of Medical Toxicology (ACMT) is as follows: The coronavirus disease 2019 (COVID-19) pandemic has created medication safety challenges affecting patients and staff. ACMT recommends modification of some health care delivery practices to provide effective care while responding to drug shortages, infection risk, and staffing changes. All practices must also consider staff safety and preservation of personal protective equipment (PPE). We encourage collaboration of physicians and clinical pharmacists at every phase of design and implementation of medication policy changes.
Background The COVID-19 pandemic requires new approaches to delivery of health care. The combination of large numbers of ventilated patients, shortages of common medications, infection risks to health care workers, and lack of effective drug treatments has created safety challenges related to drug administration. This statement by the American College of Medical Toxicology is intended to provide guidance for safe medication administration and protection of health care team members in the face of the COVID-19 pandemic. Collaboration
Supervising Editor: Mark B. Mycyk, MD * Andrew I. Stolbach [email protected] 1
Department of Emergency Medicine, Weill Cornell Medicine, New York, NY, USA
2
Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, USA
3
Minnesota Poison Control System, Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN, USA
4
Department of Pharmacy, Boston Medical Center, Boston, MA, USA
5
Department of Emergency Medicine, Boston University School of Medicine, Boston, MA, USA
6
Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA
7
Rutgers New Jersey Medical School, Newark, NJ, USA
8
Department of Emergency Medicine, MedStar Washington Hospital Center and Georgetown University School of Medicine, Washington, DC, USA
9
Johns Hopkins University School of Medicine, Baltimore, MD, USA
J. Med. Toxicol.
between physicians (including medical toxicologists) and other members of the care team in implementation of these policies is essential to optimize patient care and staff safety during this unprecedented time [1].
Staff Safety Health care workers face a risk of occupational transmission of disease that is complicated by hospital PPE shortages [2]. Patient care requires direct contact, but every encounter increases the opportunity for viral transmission and consumes PPE, which is in limited supply. Procedures that potentially generate aerosols, such as e
Data Loading...
